title: Hepatitis B virus DNA in anti-HBe-positive asymptomatic carriers.
abstract: OBJECTIVE
  We examined the level of hepatitis B virus (HBV) DNA and the mutations in the precore, core and polymerase regions of HBV in sera from anti-HBe-positive asymptomatic carriers (ASC).
  
  
  METHODS
  The amount of HBV DNA was determined semiquantitatively by mutation site-specific assay in sera from 19 anti-HBe-positive ASC and 31 HBeAg-positive patients with chronic liver disease (CLD). The mutations in the precore, core and polymerase (terminal protein) regions, spanning 1,037 nucleotides, of HBV in sera from three cases each of anti-HBe-positive ASC, HBeAg-positive ASC and HBeAg-positive CLD were examined by directly sequencing the amplified HBV DNA.
  
  
  RESULTS
  The level of HBV viremia in anti-HBe-positive ASC was significantly lower than that in HBeAg-positive CLD patients (p < 0.01). By sequence analysis, there were a few missense mutations detected in HBeAg-positive ASC and HBeAg-positive CLD patients. In contrast, many mutations, especially in the central or N-terminal half of the core region and N-terminal part of the polymerase region, were detected in anti-HBe-positive ASC.
  
  
  CONCLUSIONS
  Mutations not only in the precore/core region, but also in the polymerase region of HBV might cause damage to some important functions for efficient replication of HBV and be involved in the reduced amount of HBV in anti-HBe-positive ASC.
authors.affiliation: Department of Clinical Molecular Medicine, Division of Diabetes, Digestive and Kidney Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Seo
authors.forename: Seitetsu
authors.initials: S
authors.lastname: Yoon
authors.forename: Miyuki
authors.initials: M
authors.lastname: Nakaji
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Yano
authors.forename: Hidenobu
authors.initials: H
authors.lastname: Nagano
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Ninomiya
authors.forename: Yoshitake
authors.initials: Y
authors.lastname: Hayashi
authors.forename: Masato
authors.initials: M
authors.lastname: Kasuga
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D002353:Carrier State / Q000821:virology*; D004279:DNA, Viral / Q000097:blood*; D005260:Female; D006509:Hepatitis B / Q000821:virology*; D006510:Hepatitis B Antibodies / Q000097:blood*; D006513:Hepatitis B e Antigens / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009154:Mutation; D017422:Sequence Analysis, DNA
chemical_list: D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006513:Hepatitis B e Antigens